Women with hip implants 'may pass metal ions on to babies'

Published on 10 Mar 2010

New research suggests that women with certain types of hip implant may pass metal ions to their babies during pregnancy.

Hip replacement surgery is a treatment option for people with severe osteoarthritis, removing the damaged joint and replacing it with a synthetic one to relieve pain and restore mobility.

The ball of the joint and the surface of the socket are often both made of metal, and ions can be released from the implant as the two surfaces rub against each other.

A small new study, presented at the annual meeting of the American Academy of Orthopaedic Surgeons in New Orleans this week, has revealed that these metal ions may be passed to women's offspring during pregnancy.

Researchers analysed three women, all of whom gave birth between two and six years after receiving a metal-on-metal total hip replacement or metal-on-metal hip resurfacing.

Tests conducted on maternal and umbilical cord blood at the time of delivery revealed that both mothers and their babies had higher-than-expected levels of chromium and cobalt, both of which are found in metal hip implants.

The babies typically had cobalt levels that were half as high and chromium levels that were around 15 per cent of those found in their mothers.

Dr Joshua Jacobs, professor and chairman of orthopaedic surgery at Rush University Medical Centre, emphasised: "We don't know whether metal ions pose any health risks for pregnant women and their babies."

But he cautioned: "As metal-on-metal implants increase in popularity and use, especially among young, active patients, women of child-bearing age and their doctors need to be aware of these findings when considering options for hip replacements."

Arthritis Research UK is currently funding research into metal-on-metal hip resurfacing to find out if there are any possible biological side effects, and whether the amount of metal released from the implant has any effect on human cells.

ADNFCR-1096-ID-19661429-ADNFCR© Adfero Ltd

Share |